Anti-cervical cancer effects of Compound Yangshe granule through the PI3K/AKT pathway based on network pharmacology
Chao Ma, Yongwei Gu, Chang Liu, Xiaomeng Tang, Jianchao Yu, Dan Li, Jiyong Liu
Journal:JOURNAL OF ETHNOPHARMACOLOGY
IF:5.2
DOI:10.1016/j.jep.2022.115820
PMID:36220511
Published:2022-10-08
research field:中医药神经药理学分子信号通路脑血管疾病
Abstract
Ethnopharmacological relevance Compound Yangshe granule is a characteristic Chinese preparation against cervical cancer used at Fudan University Shanghai Cancer Center, and it consists of Hedyotis Diffusae Herba, Solani Lyrati Herba, Rubiae Radix et Rhizoma, Echinopsis Radix, Angelicae Sinensis Radix, Codonopsis Radix and Atractylodis Macrocephalae Rhizoma. Aim of the study : The objective of the current study was to investigate the preclinical efficacy of compound Yangshe granule against cervical cancer and elucidate the underlying mechanisms. Materials and methods Antitumor effect of the preparation was investigated in U14 cells in vitro and subcutaneous xenograft mice in vivo . The underlying mechanisms were investigated by through network pharmacological analysis and identified by in vitro study. The components of compound Yangshe granule were collected from the Traditional Chinese Medicine Systems Pharmacology database, and the corresponding targets were predicted by the SwissTargetPrediction database. The targets involved in cervical cancer were collected from the GeneCards, Online Mendelian Inheritance in Man and DrugBank databases. A protein‒protein interaction network was constructed by using the String platform. The drug–disease–target network was plotted by Cytoscape software. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology enrichment analyses were performed to investigate hub targets. Results After treatment with 0.5–10 mg/mL compound Yangshe granule, the survival rates of U14 cells gradually declined to 53.32% for 24 h, 23.62% for 48 h, and 12.81% for 72 h. The apoptosis rates of U14 cells gradually increased to 15.52% for 24 h, 23.87% for 48 h, and 65.01% for 72 h after treatment with 2–10 mg/mL compound Yangshe granule. After oral administration of compound Yangshe granule by xenograft mice, the tumor inhibition rates reached 52.27%, 74.62%, and 82.70% in the low, middle, and high dose groups, respectively. According to the n
本文使用的Yeasen产品


